Executive Salary
avg.$192,227
Eli Lilly and Company
Life Science/Pharmaceutical Industry/Pharmaceutical Research Industry
Indianapolis, IN, United States
Description
Eli Lilly and Company, founded in 1876 and headquartered in Indianapolis, Indiana, is a publicly traded pharmaceutical enterprise employing approximately 47,000 people. The company engages in research, development, manufacturing, and global distribution of pharmaceutical drugs, serving both B2B and B2C markets. With a revenue of around $46 billion, Eli Lilly operates across various therapeutic areas, delivering innovative medicines worldwide. Its business model includes the development of new therapies and the commercialization of a broad portfolio of pharmaceutical products aimed at improving patient health outcomes.
Experteer Insights
Experteer Briefing
Company Trajectory
Eli Lilly and Company, founded in 1876 and headquartered in Indianapolis, Indiana, has evolved from its roots in manufacturing and selling pharmaceutical drugs to become a leading global pharmaceutical firm. Over the decades, the company has marked its trajectory with the development of subsidiaries and notable innovation milestones, including the mass production of insulin, penicillin, and erythromycin. Lilly’s strategic expansion into global markets and the introduction of landmark products such as Prozac exemplify its adaptability and commitment to medical advancement. Today, the company continues to innovate and expand its therapeutic reach while maintaining its historic focus on patient health and pharmaceutical excellence.
Financial Setup
As a publicly traded entity with a workforce exceeding 47,000 employees worldwide, Eli Lilly and Company operates under a diversified financial structure that supports research, development, manufacturing, and global distribution of pharmaceutical products. The company serves both business-to-business and business-to-consumer markets, maintaining robust revenue streams through its expansive product portfolio. Its continued growth is supported by ongoing investments in both established and emerging markets, as well as a solid history of financial resilience through market shifts and healthcare industry changes.
Development & Outlook
Eli Lilly and Company maintains a strong commitment to developing innovative pharmaceutical drugs, offering treatments for conditions such as diabetes, obesity, cancer, and mental health disorders. Its research and development initiatives have yielded numerous significant patents, underlining its leadership in biotechnology and pharmaceutical innovation. Sustainability is reflected in ongoing investments aimed at advancing manufacturing practices, while social responsibility is demonstrated through initiatives like the $35 monthly insulin price cap, designed to facilitate access to essential medications. The company complies with rigorous FDA regulations and is focused on delivering new therapies and expanding its positive impact on global health in the years ahead.
Vacancies
Associate Director - Diagnostic Medical Science Liaison (DxMSL) West (CA, WA. OR, MT, WY, ID, NV, UT, AZ)
Eli Lilly and Company
Los Angeles, CA - USA
Biologist - In Vivo - Cardio Metabolic Research
Eli Lilly and Company
Indianapolis, IN - USA
Lead Auditor – Health, Safety, and Environment
Eli Lilly and Company
Indianapolis, IN - USA
Engineer - Automation Engineering – Biologics- Lilly Medicine Foundry
Eli Lilly and Company
Lebanon, IN - USA
Principal Informatics Engineer - Lilly Medicine Foundry
Eli Lilly and Company
Lebanon, IN - USA